Kanya Rajangam

Dr. Kanya Rajangam is a President & Chief Medical Officer at Senti Biosciences Holdings, Inc., a President, Chief Medical Officer, Head-R&D at Senti Biosciences, Inc. and an Independent Director at Turnstone Biologics, Inc. She is on the Board of Directors at Turnstone Biologics, Inc. Dr. Rajangam was previously employed as an Independent Director by Turnstone Biologics Corp., a Chief Medical Officer by Nkarta, Inc., a Chief Medical Officer & Senior Vice President by Atara Biotherapeutics, Inc., a Chief Medical Officer by Cleave Biosciences, Inc., an Executive Director by Nektar Therapeutics, a Senior Medical Director by Onyx Pharmaceuticals, Inc., and an Associate Medical Director by Exelixis, Inc. She received her doctorate degree from Northwestern University and a doctorate degree from St. John's Medical College.